Literature DB >> 4082281

The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization.

C A Brown, I N Brown, S Swinburne.   

Abstract

It has been postulated that previous exposure to mycobacteria in the environment may be a contributing factor to the variable efficacy of BCG vaccination in protecting against human tuberculosis or leprosy, in different geographical regions. To test this hypothesis mice were given Mycobacterium vaccae in their drinking water for 3 weeks immediately, 27 days, or 54 days before they were injected subcutaneously with BCG. Spleen cells were examined, 50 days after injection of the mice, for ability to proliferate in vitro in response to killed mycobacteria added to the cultures. The results show that, depending on the timing of the exposure of the mice in vivo to M. vaccae before BCG injection and the dose of the mycobacterial challenge in vitro, oral administration of this species of environmental mycobacteria can either enhance, mask or interfere with the expression of sensitization by BCG. Thus, our data from mice support the hypothesis that the results of BCG vaccination for a particular human population are influenced by exposure to indigenous mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4082281     DOI: 10.1016/0041-3879(85)90062-5

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  7 in total

Review 1.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

2.  Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination.

Authors:  D Elias; D Wolday; H Akuffo; B Petros; U Bronner; S Britton
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 4.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 5.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 6.  Vaccines for TB: Lessons from the Past Translating into Future Potentials.

Authors:  Gee Jun Tye; Min Han Lew; Yee Siew Choong; Theam Soon Lim; Maria Elena Sarmiento; Armando Acosta; Mohd Nor Norazmi
Journal:  J Immunol Res       Date:  2015-06-03       Impact factor: 4.818

Review 7.  The Progress of Therapeutic Vaccination with Regard to Tuberculosis.

Authors:  Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2016-09-28       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.